Top Markets
Coin of the day
UnitedHealth Group Incorporated UnitedHealth Group Incorporated

UnitedHealth Group Incorporated

UNH
Classifica tra le azioni #46
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare... UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
Prezzo delle azioni
$375.39
Capitalizzazione di mercato
$340.90B
Variazione (1 giorno)
-0.37%
Variazione (1 anno)
11.49%
Paese
US
Scambia UnitedHealth Group Incorporated (UNH)

Categoria

Rapporto P/E per UnitedHealth Group Incorporated (UNH)
Rapporto P/E al September 2026 TTM: 24.66
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di UnitedHealth Group Incorporated, il rapporto P/E attuale (TTM) è 24.66. Alla fine del 2024, il rapporto P/E era 32.62.
Storico del rapporto P/E per UnitedHealth Group Incorporated da 2000 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) 24.66 16.78%
2025 21.12 -35.27%
2024 32.62 49.45%
2023 21.83 -11.30%
2022 24.61 -10.16%
2021 27.39 27.19%
2020 21.54 6.61%
2019 20.20 0.93%
2018 20.02 -0.57%
2017 20.13 -7.29%
2016 21.71 12.58%
2015 19.29 10.29%
2014 17.49 29.85%
2013 13.47 33.60%
2012 10.08 -4.41%
2011 10.55 20.84%
2010 8.73 -6.30%
2009 9.31 -14.13%
2008 10.85 -33.89%
2007 16.41 -5.51%
2006 17.36 -31.90%
2005 25.50 19.68%
2004 21.30 2.53%
2003 20.78 10.83%
2002 18.75 -22.59%
2001 24.22 -10.39%
2000 27.03 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
24.95 1.15%
US
18.86 -23.55%
US
11.96 -51.51%
US
38.26 55.12%
US
- -
US
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.